This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Antonescu, C. R. Articles by Ladanyi, M. Search for Related Content PubMed PubMed Citation Articles by Antonescu, C. R. Articles by Ladanyi, M.

JMD 2000, Vol. 2, No. 3
Copyright © 2000 American Society for Investigative Pathology & Association for Molecular Pathology

Specificity of TLS-CHOP Rearrangement for Classic Myxoid/Round Cell Liposarcoma

Absence in Predominantly Myxoid Well-Differentiated Liposarcomas

Cristina R. Antonescu^*, Abul Elahi, Marcia Humphrey^*, Man Yee Lui^*, John H. Healey, Murray F. Brennan, James M. Woodruff^*, Suresh C. Jhanwar and Marc Ladanyi^*

From the Departments of Pathology, * Human Genetics, and Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

Myxoid liposarcoma (LS), the most common subtype of LS, is known to be characterized by the specific t(12;16) resulting in a TLS-CHOP fusion in almost all cases. We wished to address the following questions: (i) Is this genetic hallmark also present in other types of LS with predominant myxoid change? (ii) What is the proportion of cases with the variant EWS-CHOP fusion? (iii) What is the optimal approach for Southern blot detection of TLS breakpoints? We identified 59 LS characterized histologically by >90% myxoid component, in which frozen tissue tumor was available for DNA extraction. These 59 LS with myxoid features were divided into 2 groups: 42 LS with classic myxoid/round cell appearance (myxoid LS) and 17 well-differentiated LS (WDLS) with a predominant (>90%) myxoid component. Within the myxoid LS group, 29 tumors were low grade and 13 high grade (>20% round cell component). Among the 17 predominantly myxoid WDLS, there were 15 low grade and 2 focally high grade tumors. In addition, we selected as control group, 20 LS of other histological types with minimal or no myxoid change (17 WDLS and 3 pleomorphic LS) and 13 myxofibrosarcomas. Southern blot analysis was performed in all cases using a CHOP cDNA probe, and in all CHOP rearranged cases using a TLS cDNA probe. Probe/enzyme combinations for Southern blot analysis were CHOP exon 3–4 cDNA probe with BamHI or SacI, TLS exon 3–6 cDNA probe with BclI. All 42 cases of myxoid LS showed a CHOP rearrangement and 38 of them also had a TLS rearrangement. Among the 4 myxoid LS without Southern blot evidence of TLS rearrangement, 1 showed an EWS-CHOP fusion by Southern blotting and reverse transcriptase-polymerase chain reaction and in another case, reverse transcriptase-polymerase chain reaction detected a TLS-CHOP fusion transcript. None of the predominantly myxoid WDLS and none of the tumors included in the control group showed rearranegements with CHOP probe. In addition, 12 predominantly myxoid WDLS, 10 other LS, and 5 myxofibrosarcoma from the control group were also tested for TLS rearrangement; all were negative. The TLS-CHOP fusion is highly sensitive and specific for the entity of classic myxoid/round cell LS. Other types of LS, even with a predominant myxoid component, lack the TLS-CHOP rearrangement, confirming that they represent a genetically distinct group of LS. The prevalence of the EWS-CHOP variant fusion was approximately 2% in this series. The optimal enzyme for TLS genomic breakpoint detection is BclI.

This article has been cited by other articles:

				W. D. Craig, J. C. Fanburg-Smith, L. R. Henry, R. Guerrero, and J. H Barton Fat-containing Lesions of the Retroperitoneum: Radiologic-Pathologic Correlation RadioGraphics, January 1, 2009; 29(1): 261 - 290. [Abstract] [Full Text] [PDF]

				H.-Y. Huang, W.-W. Huang, J.-M. Wu, C.-K. Huang, J.-W. Wang, H.-L. Eng, C.-N. Lin, S.-C. Chou, S.-C. Yu, F.-M. Fang, et al. Flow Cytometric Analysis of DNA Ploidy and S-Phase Fraction in Primary Localized Myxofibrosarcoma: Correlations with Clinicopathological Factors, Skp2 Expression, and Patient Survival Ann. Surg. Oncol., August 1, 2008; 15(8): 2239 - 2249. [Abstract] [Full Text] [PDF]

				K. Engstrom, H. Willen, C. Kabjorn-Gustafsson, C. Andersson, M. Olsson, M. Goransson, S. Jarnum, A. Olofsson, E. Warnhammar, and P. Aman The Myxoid/Round Cell Liposarcoma Fusion Oncogene FUS-DDIT3 and the Normal DDIT3 Induce a Liposarcoma Phenotype in Transfected Human Fibrosarcoma Cells Am. J. Pathol., May 1, 2006; 168(5): 1642 - 1653. [Abstract] [Full Text] [PDF]

				W. J. Law, K. L. Cann, and G. G. Hicks TLS, EWS and TAF15: a model for transcriptional integration of gene expression Brief Funct Genomic Proteomic, March 1, 2006; 5(1): 8 - 14. [Abstract] [Full Text] [PDF]

				T. Hosaka, Y. Nakashima, K. Kusuzaki, H. Murata, T. Nakayama, T. Nakamata, T. Aoyama, T. Okamoto, K. Nishijo, N. Araki, et al. A Novel Type of EWS-CHOP Fusion Gene in Two Cases of Myxoid Liposarcoma J. Mol. Diagn., August 1, 2002; 4(3): 164 - 171. [Abstract] [Full Text] [PDF]

				C. R. Antonescu, S. J. Tschernyavsky, R. Decuseara, D. H. Leung, J. M. Woodruff, M. F. Brennan, J. A. Bridge, J. R. Neff, J. R. Goldblum, and M. Ladanyi Prognostic Impact of P53 Status, TLS-CHOP Fusion Transcript Structure, and Histological Grade in Myxoid Liposarcoma: A Molecular and Clinicopathologic Study of 82 Cases Clin. Cancer Res., December 1, 2001; 7(12): 3977 - 3987. [Abstract] [Full Text] [PDF]